There are 2789 resources available
239P - Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients
Presenter: Marzia Del Re
Session: ePoster Display
240P - A real-world data analysis: The first United Kingdom experience of cyclin-dependent kinase 4/6 inhibitor in advanced breast cancer in the National Health Service within an access program
Presenter: Carlo Palmieri
Session: ePoster Display
241P - Abemaciclib plus fulvestrant in participants with HR+/HER2- advanced breast cancer: A pooled analysis of the endocrine therapy naïve (EN) participants in MONARCH 2
Presenter: Jose Luis-Gonzalez Trujillo
Session: ePoster Display
242P - Impact of metastases directed radiation therapy on CDK4/6 inhibitors treatment for metastatic breast cancer
Presenter: Icro Meattini
Session: ePoster Display
244P - Real-world first-line treatment patterns and outcomes in hormone-receptor positive advanced breast cancer patients: A multicenter, retrospective study
Presenter: Zhanhong Chen
Session: ePoster Display
246P - Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study
Presenter: Antonios Valachis
Session: ePoster Display
194P - Stromal tumor-infiltrating lymphocyte scores in core needle biopsy and its correlation to complete pathological response to neoadjuvant systemic therapy
Presenter: Klara Gersak
Session: ePoster Display
195P - A prognostic signature based on two-miRNA and pathological data in early-stage HER2+ breast cancer patients
Presenter: Anna Adam Artigues
Session: ePoster Display